FILE:WAG/WAG-8K-20100301154553.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
On February 23, 2010, Stanley B. Blaylock, senior vice president of Walgreen Co. (the Company) and president of Walgreens Health Services, informed the Company that he will leave the Company in April after a transition period.  The exact date of Mr. Blaylocks departure and the material terms and conditions of any agreement between the Company and Mr. Blaylock have not yet been determined and will be described in an amendment to this current report.
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


